Sensus Healthcare Future Growth
Future criteria checks 4/6
Sensus Healthcare is forecast to grow earnings and revenue by 82.8% and 13.1% per annum respectively while EPS is expected to grow by 81.9% per annum.
Key information
82.8%
Earnings growth rate
81.9%
EPS growth rate
Medical Equipment earnings growth | 16.5% |
Revenue growth rate | 13.1% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 03 Apr 2024 |
Recent future growth updates
Recent updates
Potential Upside For Sensus Healthcare, Inc. (NASDAQ:SRTS) Not Without Risk
Apr 16Sensus Healthcare, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 11There's Been No Shortage Of Growth Recently For Sensus Healthcare's (NASDAQ:SRTS) Returns On Capital
Oct 17Sensus Healthcare (NASDAQ:SRTS) Might Have The Makings Of A Multi-Bagger
Jul 04Lacklustre Performance Is Driving Sensus Healthcare, Inc.'s (NASDAQ:SRTS) 26% Price Drop
Mar 14Do Sensus Healthcare's (NASDAQ:SRTS) Earnings Warrant Your Attention?
Mar 06Sensus Healthcare (NASDAQ:SRTS) Could Become A Multi-Bagger
Oct 11Sensus Healthcare Q2 GAAP EPS, revenue beats
Aug 04Sensus Healthcare: A Buy In Honor Of Skin Cancer Awareness Month
May 21Analysts Just Made A Captivating Upgrade To Their Sensus Healthcare, Inc. (NASDAQ:SRTS) Forecasts
May 11Investors Will Want Sensus Healthcare's (NASDAQ:SRTS) Growth In ROCE To Persist
Apr 29Sensus Healthcare's (NASDAQ:SRTS) Earnings Are Of Questionable Quality
Apr 01Are Investors Undervaluing Sensus Healthcare, Inc. (NASDAQ:SRTS) By 31%?
Dec 17We Discuss Why Sensus Healthcare, Inc.'s (NASDAQ:SRTS) CEO Compensation May Be Closely Reviewed
May 30Sensus Healthcare: Likely Post-Pandemic Sales Recovery Can Boost Share Price
Apr 26Analysts Expect Breakeven For Sensus Healthcare, Inc. (NASDAQ:SRTS) Before Long
Apr 19Sensus Healthcare's (NASDAQ:SRTS) Stock Price Has Reduced 30% In The Past Three Years
Feb 23Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 32 | 3 | N/A | N/A | 1 |
12/31/2024 | 26 | 1 | N/A | N/A | 2 |
12/31/2023 | 24 | 0 | -2 | -2 | N/A |
9/30/2023 | 25 | -1 | -15 | -15 | N/A |
6/30/2023 | 30 | 2 | -12 | -12 | N/A |
3/31/2023 | 38 | 6 | -11 | -10 | N/A |
12/31/2022 | 45 | 24 | -2 | -1 | N/A |
9/30/2022 | 44 | 27 | 7 | 7 | N/A |
6/30/2022 | 41 | 25 | 4 | 4 | N/A |
3/31/2022 | 34 | 21 | 4 | 4 | N/A |
12/31/2021 | 27 | 4 | 0 | 0 | N/A |
9/30/2021 | 19 | 0 | 1 | 1 | N/A |
6/30/2021 | 15 | -2 | -3 | -3 | N/A |
3/31/2021 | 11 | -4 | -2 | -2 | N/A |
12/31/2020 | 10 | -7 | -1 | 0 | N/A |
9/30/2020 | 13 | -7 | 0 | 0 | N/A |
6/30/2020 | 17 | -6 | 1 | 1 | N/A |
3/31/2020 | 24 | -3 | 5 | 5 | N/A |
12/31/2019 | 27 | -2 | -3 | -2 | N/A |
9/30/2019 | 27 | -3 | -5 | -4 | N/A |
6/30/2019 | 27 | -2 | -5 | -5 | N/A |
3/31/2019 | 26 | -3 | -13 | -12 | N/A |
12/31/2018 | 26 | -2 | -9 | -9 | N/A |
9/30/2018 | 25 | -3 | -7 | -6 | N/A |
6/30/2018 | 23 | -3 | -5 | -5 | N/A |
3/31/2018 | 22 | -3 | -4 | -4 | N/A |
12/31/2017 | 21 | -4 | -3 | -3 | N/A |
9/30/2017 | 19 | -3 | N/A | -2 | N/A |
6/30/2017 | 18 | -2 | N/A | -3 | N/A |
3/31/2017 | 16 | -2 | N/A | -3 | N/A |
12/31/2016 | 15 | 0 | N/A | -1 | N/A |
9/30/2016 | 14 | 0 | N/A | -2 | N/A |
6/30/2016 | 13 | 0 | N/A | -1 | N/A |
3/31/2016 | 11 | 0 | N/A | -1 | N/A |
12/31/2015 | 10 | -1 | N/A | -1 | N/A |
9/30/2015 | 8 | -2 | N/A | -1 | N/A |
12/31/2014 | 6 | -4 | N/A | -2 | N/A |
12/31/2013 | 10 | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SRTS's forecast earnings growth (82.8% per year) is above the savings rate (2.4%).
Earnings vs Market: SRTS's earnings (82.8% per year) are forecast to grow faster than the US market (14.5% per year).
High Growth Earnings: SRTS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SRTS's revenue (13.1% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: SRTS's revenue (13.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SRTS's Return on Equity is forecast to be high in 3 years time